Minghao Dang

Jan 23, 2025 | cell.com | Hua Wang |Keiko Akagi |Minghao Dang |Li Qin |Hans Lee |Pei Lin | +15 more

Keywordsmyeloma precursorsdisease progressionscRNA-seqscBCR-seqLAMP5MAT2AIntroductionMultiple myeloma (MM) is a largely incurable malignancy characterized by the accumulation of transformed plasma cells (PCs) in the bone marrow (BM).

Jan 9, 2025 | nature.com | Pavlos Msaouel |Rahul Sheth |Amishi Y. Shah |Amado J. Zurita |Giannicola Genovese |Minghao Dang | +3 more

AbstractWe conducted a phase I trial to determine the optimal dose of triplet therapy with the tyrosine kinase inhibitor sitravatinib plus nivolumab plus ipilimumab in 22 previously untreated patients with advanced clear cell renal cell carcinoma. The primary endpoint was safety.